A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.
Clinical trial NCT03840200 · COMPLETED
Trial details
- NCT number
- NCT03840200
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-12
- Primary completion
- 2021-12-07
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.